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SUMMARY
The mode of regulation of Src kinases has been elucidated by crystallographic studies identifying 
conserved structured protein modules involved in an orderly set of intramolecular associations and 
ligand interactions. Despite these detailed insights, much of the complex behavior and diversity in 
the Src family remains unexplained. A key missing piece is the function of the unstructured N-
terminal region. We report here the function of the N-terminal region in binding within a 
hydrophobic pocket in the kinase domain of a dimerization partner. Dimerization substantially 
enhances autophosphorylation and phosphorylation of selected substrates, and interfering with 
dimerization is disruptive to these functions. Dimerization and Y419 phosphorylation are 
codependent events creating a bistable switch. Given the versatility inherent in this intrinsically 
disordered region, its multisite phosphorylations, and its divergence within the family, the unique 
domain likely functions as a central signaling hub overseeing much of the activities and unique 
functions of Src family kinases.
In Brief
Spassov et al. report that Src exists in cells and functions as a dimer and that dimerization and 
autophosphorylation are codependent events. Through a comprehensive structure-function 
analysis, they show that the dimer is an asymmetric dimer held through the interaction of the 
myristoylated N-terminal unique domain of one partner with a hydrophobic pocket in the kinase 
domain of another.
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INTRODUCTION
The Src family kinases (SFKs) are a closely related family of non-receptor tyrosine kinases 
that play important roles in many different cellular signaling pathways (Erpel and 
Courtneidge, 1995; Parsons and Parsons, 2004; Thomas and Brugge, 1997). Their 
participation in such a wide repertoire of cellular pathways and the plethora of substrates 
phosphorylated by SFKs preclude the assignment of a unique function to this family, and it 
appears that SFKs play a fundamental role in regulating many aspects of metazoan life. The 
SFK family encompasses 11 members in humans by the Manning classification, including a 
core group of closely related members Src, Yes, Fyn, Fgr, Blk, Hck, Lck, and Lyn and a 
more distantly related group of Frk, Srm, and Brk (Manning et al., 2002). Src, Yes, and Fyn 
are widely ex-pressed in most tissue types, whereas the other members have a much more 
restricted expression pattern. All SFKs share a simple modular domain structure consisting 
of SH3, SH2, and catalytic kinase domains (KDs) followed by a short C-terminal tail, all of 
which are highly homologous within the family. However, N-terminal sequences of ~70–80 
residues are entirely divergent imparting a unique identity and possibly unique and 
nonredundant function to individual members. The more closely related core SFK members 
also share a few residues at the extreme N terminus following cleavage of the starting 
methionine, providing a recognition motif for myristoylation of the N-terminal glycine by 
N-myristoyl transferase (NMT) (Resh, 1994, 1999). This motif, along with several charged 
amino acids within the first 10–17 residues that enhance affinity to membrane lipids, is 
referred to as the SH4 domain and accounts for the localization of these SFKs to membranes 
(McCabe and Berthiaume, 1999; Resh, 1994).
Decades of efforts have revealed considerable insights into how the activities of SFKs are 
regulated by their modular structure (extensively reviewed in Boggon and Eck, 2004; 
Roskoski, 2004; Sicheri and Kuriyan, 1997; Xu et al., 1999). Key determinants of their 
activity are phosphorylation and protein-protein interactions. Phosphorylation at Tyr 527 
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(using chicken c-Src numbering) by C-terminal Src kinase (CSK) is inhibitory, while 
phosphorylation at Tyr 416 is activating, although neither of these phosphorylations by 
themselves exert full positive or negative regulatory control. Pioneering crystallographic 
studies reveal that Src is held in an autoinhibited state by intramolecular interactions 
wherein the SH2 domain is bound to its phosphorylated C-terminal Tyr 527 and the SH3 
domain engages a proline-rich SH2-KD linker region and the kinase N-lobe. In this state, the 
active site of the KD is disrupted by displacement of the aC helix. These intramolecular 
interactions are weak in nature and can be destabilized by solicitation of the SH2 and SH3 
domains by higher-affinity ligands (Moarefi et al., 1997) or by dephosphorylation of Tyr 527 
by a number of phosphatases (Roskoski, 2005). Auto-phosphorylation at Tyr 416 stabilizes 
the activation loop, an event that in most kinases is required for catalytic activity. Thus, the 
selection of substrates by Src is directly influenced by ligand recognition via the SH3 and 
SH2 domains and not simply by the substrate motif preferences of its catalytic domain active 
site in what has been termed the “turned on by touch” mode of signaling (Boggon and Eck, 
2004). As such, the activities of SFKs are greatly affected by their molecular surroundings. 
These structural modules are highly homologous across the entire family, leaving 
unanswered why the family is so large and how individual members can perform unique 
functions.
A key feature of SFKs that is missing in current models of their regulation is their unique 
domains (UDs). This is because the UD is intrinsically disordered and has eluded analysis in 
the crystallographic studies that have informed much of our current understanding of SFK 
regulation. However, considerable lines of evidence suggest that the UD is critically 
involved in the regulation of SFKs. Although the UD sequences are not conserved between 
family members, they are well conserved across species, suggesting that it is not merely a 
spacer region but rather harbors specific functions. Furthermore, although there is little 
sequence homology between the UDs of SFKs, studies using nuclear magnetic resonance 
(NMR) and small-angle X-ray scattering reveal compaction of the UD mediated through 
several long-range interactions between aromatic residues that are conserved within the SFK 
family, suggesting that these disordered regions share at least some common structural 
features (Arbesú et al., 2017). The UDs of individual SFK members confer specific 
signaling functions distinct from other members, and in fact some of these functions can be 
lost by UD deletion or transferred by UD-swapping experiments (Carrera et al., 1995; Hoey 
et al., 2000; Summy et al., 2003; Wer-dich and Penn, 2005). Further consistent with a 
regulatory function, the UDs of SFKs are phosphorylated and dephosphorylated on several 
sites, affecting their signaling functions (Amata et al., 2013, 2014; Hansen et al., 1997; 
Johnson et al., 2000; Joung et al., 1995). How these phosphorylations regulate function 
remain largely unknown, awaiting more mechanistic insights into the functions of the UD. 
The most detailed function described thus far is for the UD of Lck. Lck binds the T cell co-
receptors CD4 and CD8 on the surface of T lymphocytes through its UD (Shaw et al., 1989). 
Although its UD is unstructured in isolation, it adopts an organized heterodimeric solution 
structure when complexed with zinc and the cytoplasmic tails of CD4 or CD8, providing a 
glimpse of how this disordered region can mediate a highly specific interaction that enables 
Lck to function as a second messenger signaling molecule for these surface receptors (Kim 
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et al., 2003). Such a function has yet to be demonstrated for any other SFK UD, and in fact 
more recent efforts seem to imply considerable versatility in the functions of UDs.
The interest in understanding the functions of intrinsically disordered proteins (IDPs) or 
intrinsically disordered regions (IDRs), such as the UD of SFKs, has exploded in recent 
years as the sheer abundance and relevance of IDPs and IDRs in the eukaryotic proteome 
has become apparent (Dunker et al., 2002; Wright and Dyson, 1999, 2015). IDPs frequently 
exhibit multiple interaction capabilities and function as protein interaction hubs in cell-
signaling networks (Dunker et al., 2005; Kim et al., 2008). Although intrinsically disordered, 
they often contain small elements that fold upon binding to protein targets, mediating 
interactions characterized by high specificity but modest affinity. Such interactions begin 
and end with rapid kinetics and thus are highly dynamic and often transient (Dyson and 
Wright, 2005; Wright and Dyson, 1999). The modest affinities of IDPs allows for a 
substantial degree of regulation through post-translational modifications, enabling them to 
function as signaling hubs (Borg et al., 2007; Gsponer and Babu, 2009; Van Roey et al., 
2012, 2013). The emerging evidence and the developing paradigms for how IDRs can 
mediate key regulatory functions has renewed our interest in understanding the functions of 
the disordered UDs at the N-terminal region of SFKs.
In this work, we began by asking whether SFKs signal as dimers, what structural elements 
may be mediating the formation of such dimers, and how dimerization affects signaling 
function. The evidence implicates the UD along with the N-terminal myristoylation as 
critical mediators of dimerization and highly relevant for kinase activity and substrate 
phosphorylation.
RESULTS
Src Forms Dimers Involving the SH4-UD and KD Regions
Dimerization is a key mechanism mediating the signaling functions of many protein kinases. 
However, a role for dimerization has not been described for SFKs. We began this study by 
asking whether Src dimerizes, and if so, to determine the structural determinants that 
mediate dimerization and the potential relevance of dimerization in Src signaling. Constructs 
were generated using the full-length human c-Src or various deletion mutants lacking one or 
more of its functional domains. The structures and nomenclature used for all these 
constructs are schematically depicted in Figure 1. All constructs were generated in duplicate 
with either a hemagglutinin (HA) tag or a FLAG tag at the C terminus, enabling simple 
detection of dimerization through HA or FLAG co-immunoprecipitation assays. Transient 
transfection of these constructs was done in SYF cells (Src-Yes-Fyn null), which lack the 
expression of the SFK family in order to eliminate any background effects related to 
competition from endogenously expressed SFK proteins. The transfection efficiencies are 
high and the expression levels achieved in these experiments are roughly comparable to the 
endogenous expression of Src in many human cell lines, and thus the interactions detected in 
these studies are not due to artifactually high expression (Figure S1). The high transfection 
efficiency of GFP and full-length Src provides a reasonable estimate of this transfection 
technique in this cell type, although there may be differences in efficiency among the many 
different mutant constructs used.
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From these HA or FLAG co-immunoprecipitation assays, it is clear that Src forms dimers 
(Figure 2A). Dimerization of Src requires the N-terminal region containing the SH4 and UD 
(Figure 2B, lane 3 versus lane 7; Figure 2C, lane 1 versus lane 2). Dimerization is 
maintained in constructs lacking the SH3-SH2 domains (Figure 2B, lane 3). Dimerization is 
greatly impaired, although not completely lost, in constructs lacking the UD and SH3-SH2 
domains but maintaining the SH4 domain (Figure 2B, lane 5). Dimerization is also greatly 
impaired, although not completely lost, in constructs lacking myristoylation due to G2A 
mutation (Figure 2C, lane 3). The SH3-SH2 domains have no ability to dimerize with 
themselves (Figure 2D, lane 5) and are dispensable for dimerization of full-length Src 
(Figure 2B, lane 3). The KD has no ability to dimerize with itself (Figure 2B, lane 7); 
however, the KD is not dispensable for the dimerization of Src, and constructs lacking the 
KD are impaired in dimerization (Figure 2D, lane 3). The N-terminal SH4-UD segment is 
not able to dimerize with itself. This cannot be demonstrated through the simple expression 
of an SH4-UD segment, since this instrinsically disordered segment by itself is unstable and 
very poorly expressed (Figure S2). However, the SH4-UD region fused to mCherry is stable 
and expressed and shows no detectable self-dimerization (Figure 2E). Taken together, these 
data suggest that the N-terminal SH4-UD region and the KD region are the functional 
determinants of dimerization. Both myristoylation and the adjacent UD region have 
functions that contribute to the dimerization of Src. This is evident in assays using constructs 
that lack only the UD domain or constructs that are defective in myristoylation due to 
mutation of the myristoylated glycine 2 residue. In these assays, separate deletion of 
myristoylation or the UD region partially, but not completely, diminishes dimerization 
(Figures 2B and 2C).
Dimerization Is Asymmetric
The assays described above query the dimerization of identical constructs. In experimental 
designs that query the dimerization of nonidentical constructs, it is evident that the N-
terminal SH4-UD is only required on one partner for dimerization (Figure 2G, lane 2). A 
partial decrease in dimerization is evident when the SH4-UD region is present in only one 
partner. On the other hand, the deletion of the KD in either partner prevents dimerization 
(Figure 2H, lanes 2 and 3). This implicates a more complex role for the KD, which is 
explored further below.
Dimerization Is Direct
The observed interaction of Src proteins is a direct interaction and not a molecular 
proximation afforded by larger cellular macromolecular protein complexes. This is evident 
when recombinant purified HA-tagged and FLAG-tagged Src proteins are incubated by 
themselves in vitro (Figure 2I). Purified Src run on a native gel migrates in two molecular 
weight forms consistent with monomers and dimers (Figure 2J). The relative ratio of 
monomers to dimers in this assay is likely not a faithful reflection of in-cell dimerization due 
to dimer disruption by the stringent purification process. Larger oligomeric forms may also 
be potentially disrupted during purification, and the macromolecular environment of Src in 
cells may involve larger forms. The cell-based assays suggest that the minimal regions 
necessary for dimerization are the N-terminal region and the KD. The interaction of these 
two domains can also be recapitulated in vitro. While the N-terminal SH4-UD region cannot 
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be expressed and purified by itself, it is stable and can be purified when fused with 
glutathione S-transferase (GST). This recombinant purified SH4-UD-GST protein binds a 
purified KD, confirming the affinity of the N-terminal region of Src with the C-terminal KD 
of Src (Figures 2K).
Src Dimerization Is Directly Evident in Living Cells
The dimerization of Src observed in co-immunoprecipitation assays is an in-cell interaction 
and not a post-lysis artifact. For more direct evidence of Src dimerization in living cells, we 
took an orthogonal approach using a protein fragment complementation assay. The 
complementation of fragmented SNAP tags is particularly useful to detect stable protein-
protein interactions, as it is not complicated by the irreversible complementation seen with 
many split fluorescent proteins (Mie et al., 2016). The signal generated by the 
complementation of split SNAP tags fused to the C terminus of Src provides direct evidence 
in living cells of Src dimerization (Figure 3). The dimer-ization observed in this assay 
requires the N-terminal SH4-UD of Src, consistent with the biochemical studies discussed 
above (Figure 3).
Y419 Phosphorylation and Open Conformation Are Required for Src Dimerization
The dimerization of Src is linked with its activation state and conformational dynamics. 
Dimerization is promoted by the open active state of Src, and the closed tethered state is 
nonpermissive to dimerization. This is evident in dimerization assays using the Y530F 
mutant that promotes the open state by destabilizing the Y530-SH2 interaction (Liu and 
Pawson, 1994) or using the 530YEEI mutant that promotes the closed state by stabilizing the 
Y530-SH2 interaction (Schindler et al., 1999) (Figure 4A). Auto-phosphorylation of Y419 is 
required for dimerization, as evident in Y419F mutation analysis (Figure 4B). This is also 
evident in kinase-dead constructs that cannot auto-phosphorylate and thereby fail to 
dimerize (Figure 4C). Experiments with kinase inhibitors shed more subtle insights into the 
requirement for autophosphorylation in dimerization. If Src inhibitor treatment is applied 
immediately upon Src expression, then dimers will not form (Figure 4D, lane 2). However, if 
Src is inactivated long after its expression and dimerization, then preformed dimers are not 
disrupted despite clear dephosphorylation of Y419 (Figure 4D, lane 3; Figure S3). The 
observed reduction of dimerization following 1 hr of late Src inhibitor exposure is not due to 
disruption of preformed dimers; rather, it is due to the natural turnover of Src and the 
inhibition of dimerization in newly expressed Src molecules. This becomes most evident if 
the late initiation of Src inhibitor treatment is allowed to continue for a prolonged time 
frame beyond the life-time of Src proteins that may have been previously engaged in dimers 
(Figure 4D, lane 4). These experiments are consistent with the scenario wherein 
autophosphorylation of Y419 is a prerequisite for dimerization but is thereafter dispensable 
once the dimer is formed.
Y419 Phosphorylation and the SH4-UD Are Required in cis
Assay designs querying the dimerization of nonidentical constructs provide more clarity 
regarding the requirement for kinase activity and autophosphorylation in dimerization. 
Autophosphorylation at Y419 is required only in one partner for dimerization (Figure 4E, 
lanes 6 and 7). Since the N-terminal region was also shown to be required in only one 
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partner, a logical next question is whether these two requirements are in cis or in trans. 
Comparing dimerization in a variety of experimental arms designed to test whether the N-
terminal region and the Y419 autophosphorylation are required in cis or in trans, it is evident 
that this requirement is in cis (Figure 4E, lane 6 versus lane 7). Similarly, an assay designed 
to test whether the N-terminal region and catalytic kinase activity are required in cis or in 
trans revealed that this requirement is also in cis (Figure 4F, lane 3 versus 4). Taken together, 
this means that for dimerization to occur, partner A must contain an SH4-UD region and be 
auto-phosphorylated on its Y419 in order to dimerize with partner B. The 
autophosphorylation of Y419 is an intermolecular phosphorylation involving another partner 
A, as Src does not have the ability for intramolecular Y419 autophosphorylation. The fact 
that Y419 autophosphorylation is an intermolecular event was demonstrated in a more 
specifically designed experiment using the K298M kinase-dead mutant of Src. Constructs 
were generated that contain the 20-kDa C-terminal SNAP tag. These constructs migrate 
higher on gels, allowing for easy identification of simultaneously expressed tagged and 
untagged forms of Src. In this experimental design, it is evident that the kinase-dead mutant 
of Src is autophosphorylated on Y419 in an inter-molecular event by a wildtype Src (Figure 
4G, lanes 4 and 5).
Dimerization Involves the N-Terminal Myristate Binding to a KD Pocket in trans
The evidence thus far identifies the SH4-UD region as well as the KD to be determinants of 
Src dimerization. How these regions can mediate dimerization is not evident from our 
current understanding of Src structure, since the SH4-UD domain is intrinsically disordered 
and almost all of the X-ray crystallographic studies have been performed on constructs 
lacking the N-terminal region or lacking myristoylation. Studies of the closely related Abl 
kinase provide some insights into potential binding interfaces. Abl is myristoylated similar 
to Src. However, the myristoyl moiety can engage in an intramolecular interaction with the 
KD (Hantschel et al., 2003; Nagar et al., 2003). In this interaction, the myristoyl moiety 
embeds deep into a hydrophobic pocket within the base of the C-lobe of the KD (Figure S4). 
This engagement of the myristate group induces conformational changes in the C-lobe that 
affects its regulation (Nagar et al., 2003). Crystallographic studies of Src show structural 
features at this site of the KD that could potentially also bind myristate, and this is supported 
by NMR studies (Cowan-Jacob et al., 2005). In structural alignment, the overall architecture 
of this myristoyl pocket in Abl and Src appear nearly identical (Figure S4). To explore the 
possibility that this type of myristate-KD interaction may mediate the dimerization of Src, 
we focused on mutational studies of this hydrophobic pocket in Src (Figure 5A). Several 
bulkier residues lining this pocket were mutated to alanine, opening up this pocket in the KD 
of Src, potentially making it more permissive to myristate binding. These mutations, to 
varying degrees, increase the dimerization observed between the KD segment and the N-
terminal region of Src (Figure 5B). On the other hand, T459 is a lone small amino acid at the 
gate of this pocket, and a T459F mutation introduces a bulkier residue into this site, making 
it more restrictive for myristate binding. Consistent with this, the T459F mutation decreases 
the dimerization observed between the KD and the N-terminal region of Src (Figure 5C). 
Taken together, these studies support the hypothesis that dimerization involves the 
interaction of the myristoylated N-terminal region on one partner with the KD hydrophobic 
pocket in another. Alternatively it remains possible that an intramolecular myristate-KD 
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interaction forces a conformational state that exposes another dimerization interface. To 
distinguish between these possibilities, the restrictive T459F mutation or the more 
permissive L494A mutation were introduced into the KD either in cis or in trans with the 
SH4-UD region. In these experiments, it is evident that the restrictive T459F mutation 
diminishes dimerization only when it is introduced in trans with the SH4-UD domain 
(Figure 5D, lane 2 versus lane 3), and similarly, the more permissive L494A mutation 
enhances dimerization only when it is introduced in trans with the SH4-UD domain (Figure 
5E, lane 2 versus lane 3). These experiments are most consistent with a mode of 
dimerization wherein the N-terminal region of one partner binds to the KD of the other 
partner.
The binding of the myristate to the KD would be expected to come at the cost of membrane 
localization, since it would no longer be available for embedding into the plasma membrane. 
Consistent with this, the mutations that increase myristate-KD binding demonstrate a 
decrease in membrane localization, whereas the mutations that decrease myristate-KD 
binding demonstrate an increase in membrane localization (Figure S5). The myristate-KD 
binding is also potentially subject to competition by appropriately designed small-molecule 
inhibitors. Such inhibitors have been developed that bind the myristate-binding pocket in 
Abl (Zhang et al., 2010) (Figure S4D). This allosteric inhibitor of Abl, although not 
specifically designed for the analogous hydrophobic pocket in Src, does show some weak 
activity in increasing the membrane localization of Src, consistent with its ability to at least 
partially compete out the myristate-KD interaction (Figure S5D). These data are consistent 
with the notion that the observed dimerization of Src is mediated through myristate binding 
within the hydrophobic pocket of the KD analogous to Abl. Whether the UD segment also 
makes specific interactions with residues on the KD C-lobe is not addressed by these 
experiments, although numerous experiments with deletion constructs described earlier 
reveal that both myristoylation and the UD segments are important for dimerization.
N-Terminal Region Enhances Kinase Activity
The N-terminal region of Src is not only important in its dimerization but also contributes to 
kinase activity. Deletion of the N-terminal SH4-UD region reduces Src autophosphorylation 
(Figure 6A). This impairment of Src autophosphorylation activity is not due to increased 
Y530 phosphorylation (Figure 6A) and cannot be rescued by forcing the open and active 
conformation through Y530F mutation (Figure 6B). Both the myristoyl moiety and the UD 
contribute to activity with a greater impact from the loss of myristoylation. Myristoylation 
may directly enhance catalytic activity by its binding to the KD or alternatively may mediate 
an increase in substrate phosphorylation through localization effects or endorsing a specific 
molecular microenvironment. As an example, the catalytic activity of the Src-related 
cytoplasmic Abl kinase is known to be regulated by its myristoylation signal (Hantschel et 
al., 2003). To more directly explore the role of the N-terminal SH4-UD region in the 
catalytic activity of Src inde-pendent of their effects on compartmentalization, we turned to 
in vitro kinase assays. Src was expressed and purified from HEK293T cells so that it may be 
properly myristoylated (Figure 6C). Assay conditions were established to be in linear range 
with respect to duration and concentration (Figure S6). Deletion of the N-terminal SH4-UD 
region substantially diminishes the kinase activity of Src measured through its 
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autophosphorylation (Figure 6D). These are partial decreases relative to wild-type, and the 
elimination of myristoylation has a bigger impact than the elimination of the UD (Figures 
6D, 6E, and S6). Partial differences can also be appreciated in cell-based experiments by 
increasing expression levels through increasing plasmid DNA amounts transfected (Figure 
S7). Similar results are obtained when assaying the kinase activity of Src against purified 
substrates, including paxillin, enolase, or Trask/CDCP1 (Figure 6F). The concentration-
activity relationship of wild-type (WT) Src is consistent with an increase in specific activity 
as a function of concentration (Figure 6E), a finding that is consistent with a dimerization-
driven mode of activation. Although it is difficult to compare soluble protein concentrations 
in vitro to compartmentalized proteins in cells, the cellular concentration of Src is estimated 
to be in the 1–10 nM range (Gee et al., 1986; Milo et al., 2010), and thus these in vitro 
experiments are in a concentration range that can potentially inform physiologic behavior. 
More-over, disruption of Src N-terminal myristoylation in several human cell lines by a 
selective inhibitor of N-myristoyltransferase also diminishes Src autophosphorylation and 
phosphorylation of the substrate FAK (Figures 6G and 6H), although in the cellular context, 
effects on subcellular or molecular localization may also be contributing to the observed 
effects.
Dimerization Is Required for Signaling Activity
Interfering with kinase activity or Y419 autophosphorylation prevents dimerization as shown 
by the mutational and drug inhibition studies described above. The reverse also holds true, 
such that interfering with dimerization interferes with the cellular phosphorylation activities 
of Src. This was determined by the identification and use of constructs that can interfere 
with dimerization in a dominant-negative manner. The Y419F-K298M-Y530F triple mutant 
of Src, which lacks its two main regulatory phosphorylation sites and is also kinase dead, 
has been used in the field as a dominant-negative version of Src. Our studies would suggest 
that this triple mutant exerts its dominant-negative activities by interfering with the 
dimerization of Src. Consistent with this notion, this triple-mutant Src, while deficient at 
self-dimerization, does bind with WT Src and diminishes the autophosphorylation activity of 
WT Src and the transphosphorylation activity of the substrate FAK (Figure 7A). Since we 
have shown that dimerization is mediated through the N-terminal SH4-UD region, we 
should be able to reproduce this dominant-negative or inhibitory activity through the 
expression of a competing SH4-UD segment alone. Indeed, we find through stepwise 
deletion of the KD and SH3-SH2 regions of this dominant-negative construct that its 
dominant-negative function is preserved and in fact enhanced by the smaller constructs, 
possibly related to higher expression of these smaller constructs (Figure 7B). The minimal 
SH4-UD region by itself is unstable and not expressed, but a GFP-fused version is well 
expressed and demonstrates that the inhibitory activity is entirely contained within this 
minimal region (Figure 7B, lane 5). More detailed analysis of this minimal SH4-UD-GFP 
construct reveals that it binds WT Src and successfully outcompetes a WT Src partner in the 
process, and the result is inhibition of Src Y419 autophosphorylation activity and inhibition 
of phosphorylation of its substrate, FAK (Figure 7C).
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DISCUSSION
The experiments here provide structural and functional insights into the dimerization of Src. 
They show that Src does dimerize and that dimerization is mediated by the myristoylated N-
terminal region of one partner and the hydrophobic pocket within the KD C-lobe of the other 
partner. Dimerization requires Y419 phosphorylation in cis with the N-terminal region but is 
dispensable after dimer formation. The fact that Y419 phosphorylation is required for 
dimerization is corroborated by Y419F mutation, kinase-dead Src mutants, and kinase 
inhibitor studies. But why phosphorylation of Y419 in cis is required for the N-terminal 
region to engage the KD of a partner in trans is not immediately clear. Stable protein 
interactions often involve intermediate conformational states and it is possible that the Y419 
phosphorylated state of Src provides an appropriate platform for a transient conformation 
that precedes the more stable dimeric state. It is also possible that when Src is not 
phosphorylated at Y419, the N-terminal region is bound to specific proteins or engaged in a 
specific conformational state and that Y419 phosphorylation releases it from such a state, 
making it available for dimerization. Regardless of the structural basis, the functional link 
between Y419 phosphorylation and dimerization provides important clues regarding the role 
of Y419 phosphorylation in the activities of Src kinases. In the earliest days of this field, 
Y419 phosphorylation was thought to be integral to the activation process of Src because of 
reduced signaling and biologic activities observed with Y419F mutation of Src and 
emerging evidence from other kinases that phosphorylation in the activation loop of kinases 
is essential for access to the active site (Adams, 2003; Nolen et al., 2004). But numerous 
lines of evidence proved inconsistent with this generalization. The Y419F mutation only 
produces partial changes in observed activities, and these appear to be context dependent, 
possibly substrate dependent, discordant between in vitro and in-cell experiments, and not 
observed in all circumstances (Boerner et al., 1996; Ferracini and Brugge, 1990; Kmiecik 
and Shalloway, 1987). In in vitro kinase reactions, substrate phosphorylation occurs in 
competition with Y419 autophophorylation (Sun et al., 2002). Furthermore, the Y419F 
mutant of Src retains activity in vitro (Ferracini and Brugge, 1990; Piwnica-Worms et al., 
1987), as does the Y419A mutant of Hck (Porter et al., 2000). In some cell signaling 
functions, Y419 phosphorylation appears redundant. For example, Src catalytic activity is 
required to phosphorylate FAK and mediate integrin signaling and cell spreading and 
migration, yet this integrin-induced function is performed without a detectable induction in 
Y419 phosphorylation of Src and is unmitigated by the Y419F mutation of Src (Cary et al., 
2002). Furthermore, the v-src oncogene retains its tumorigenic properties despite Y416F 
mutation (analogous to human Y419F) (Snyder and Bishop, 1984). Cowan-Jacob et al. 
(2005) reported crystallographic studies of the unphosphorylated form of Src, revealing the 
A-loop to be in the open extended state with the active site exposed, consistent with the 
conformation of an active kinase. The active conformation was seen regardless of whether 
the kinase was bound to an inhibitor or AMP-PNP or in apo form. Although seemingly not 
required to stabilize its extended conformation, it was hypothesized that Y419 
phosphorylation of the A-loop may facilitate binding certain substrates. It is clear now that 
while Y419 phosphorylation alters the biologic behavior of Src, this is not due to on or off 
switching of catalytic activity. Our studies establishing a functional link between Y419 
phosphorylation and dimerization provide further insights into the role of Y419 
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phosphorylation. Our findings suggest that Y419 phosphorylation, by enabling dimerization, 
may promote Src to participate in specific macro-molecular complexes and thereby affect 
substrate access and selection by Src, affecting its functions in this more specific way rather 
than a nonspecific activation of catalytic function. It is possible that monomeric Src has 
biologic actions distinct from dimeric Src and that Y419 phosphorylation can dictate this 
transition. While our study establishes the existence and importance of Src dimerization, the 
techniques used here do not rigorously address the stoichiometry of dimerization. Future 
lines of study will more specifically need to determine how much of Src is involved in 
monomers versus dimers versus larger oligomers and establish the dynamics of these macro-
molecular events using techniques more suited for these queries.
The fact that Y419 autophosphorylation is required for dimerization (Figure 4) and that 
dimerization is required for Y419 autophosphorylation (Figure 7) presents a seemingly 
difficult regulatory relationship to reconcile at first glance, since it seems to present a 
substantial barrier for the establishment of an autophosphorylated Src dimer. But this likely 
proceeds through transient unstable states of dimerization without phosphorylation or vice 
versa and a high threshold to adopt an initial stable phosphorylated dimer. This, in fact, 
describes a bistable switch common in biologic systems. While some signaling events in 
biological systems provided graded outputs operating like a rheostat, other signaling events 
in nature provide binary outputs, operating like a switch in the on or off positions. Such 
biological systems are stable in the off position and stable in the on position and are thus 
called bistable switches (Chatterjee et al., 2008; Pomerening, 2008). The barrier to activation 
in such bistable switches functions to ensure that the signal is not activated prematurely, and 
the self-perpetuating mechanism functions to ensure continuous and sustained output once 
activated, functioning as a sort of biology memory for an initiating signal that does not itself 
persist. The relationship between Src autophosphorylation and dimerization appears to 
describe such a bistable switch and suggests a binary signaling mode of output inherent in at 
least some of the functions of the Src family.
Many kinases are known to dimerize, although the modes of dimerization vary considerably 
between kinase families (Lavoie et al., 2014). The best-understood function of dimerization 
is the regulation of the on or off state of kinases through orthosteric or allosteric 
mechanisms. In the case of Src kinases, the observed bistable switch linked with 
dimerization is unlikely to correspond to catalytic on or off states. Consistent with this, and 
as described above, the Y419F mutant of Src is impaired in dimerization yet retains activity 
in in vitro and in vivo studies. More likely, the dimerization of Src affects its biologic 
behavior, perhaps including access to specific macromolecular complexes or engagement of 
specific substrates. The fact that the N-terminal region mediates dimerization when binding 
a partner KD yet mediates membrane localization when embedding in the plasma membrane 
creates a functional competition that may have additional relevance to the regulation of the 
activities of Src kinases. The N-terminal region is also known to mediate interactions with 
other proteins (Shaw et al., 1989; Vonakis et al., 1997), also potentially in competition with 
its dimerization function, providing yet another layer of complexity in the functions of this 
region. The multifunctional nature of the N-terminal domain is likely enabled by its lack of 
an ordered structure, allowing it to adopt different conformations during interactions with 
different partners. The flexibility inherent in the UD makes it an attractive candidate as a 
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regulatory hub that governs the overall activities of Src kinases. Adding additional layers of 
diversity is that fact that dimerization in the Src family is not restricted to homodimers. We 
also readily detect Src-Fyn heterodimers and Fyn-Fyn homodimers in similar HA or FLAG 
pulldown assays (not shown). Since the N-terminal UDs are divergent between Src family 
members, the existence of various homodimeric and heterodimeric complexes of Src kinases 
creates even broader diversity in potential signaling activities associated with the various 
homo- and heterodimers.
Our understanding of the mechanisms underlying the regulation of Src kinases was largely 
informed by the crystallographic studies of the late 1990s. These developments came during 
an era of pioneering studies revealing how structured protein modules have evolved to 
regulate protein function. Now, two decades later, many of the complexities in the Src family 
remain difficult to explain, and current models of Src regulation have major conceptual gaps 
that await deeper insights. These gaps may potentially be filled by a new leap in proteomics, 
recognizing the sheer abundance and functional significance of unstructured protein regions. 
Indeed, we may have underestimated the importance of the N-terminal region of Src kinases, 
and this unstructured region may underlie much of the complexity inherent in the functions 
of this kinase family. This would be consistent with an increasing body of evidence 
regarding the critical role of IDRs in regulating protein function. These regions can harbor 
structural plasticity, adopting different structures on different targets (Dyson and Wright, 
2005), or they can bind via dynamically heterogeneous conformations, or they can bind 
without any apparent order (Baker et al., 2007; Mittag et al., 2010; Tompa and Fuxreiter, 
2008; Wang et al., 2011). The conformational entropy inherent in IDRs facilitates the 
allosteric coupling of protein domains, placing IDRs at the heart of the processes that 
regulate protein functions. Since the interactions of IDRs are based on limited or transient 
structural features and lower-affinity interactions, they are much more affected by post-
translational modifications, and it is well appreciated that IDRs are a hub for the regulation 
of protein function through post-translational modification (Borg et al., 2007; Gsponer and 
Babu, 2009; Van Roey et al., 2012, 2013). Indeed, post-translational modifications of the 
proteome are biased toward IDRs, including phosphorylation, glycosylation, hydroxylation, 
acetylation, sulfation, ADP ribosylation, SUMOylation, and ubiquitination (Iakoucheva et 
al., 2004; Pejaver et al., 2014). The N-terminal region of Src is no exception to this and is 
known to undergo multiple phosphorylations with consequent affects in its observed 
activities (Amata et al., 2013, 2014; Hansen et al., 1997; Johnson et al., 2000; Joung et al., 
1995). The presence of other post-translational modifications of the N-terminal UD of Src 
has not been studied to date, but our work provides a compelling case that the functions of 
Src kinases may be regulated in part by post-translational modification of the N-terminal 
UD. IDRs such as the UD of Src can function as signaling hubs, coordinating the activities 
of Src kinases in response to specific modifications. Such modifications can bias the binding 
affinities of the N-terminal region between the KD of a dimerization partner, the plasma 
membrane, or an interacting protein or cytoskeletal macromolecule.
The dimerization of Src has been considered and detected by other studies but with 
conflicting results and no functional insights. Weijland et al. (1997) purified and studied a 
truncated Src protein missing the N-terminal SH4-UD region and found it to be monomeric 
by gel filtration chromatography, consistent with our findings using a similarly truncated 
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construct. Kemble and Sun (2009) studied bacterial purified Src with an interest in redox 
effects and reported that oxidation induces a covalent dimerization of Src in vitro mediated 
through disulfide Cys bridging. Irtegun et al. (2013) reported Y416 phosphorylation in the 
closed state of Src and in their studies conducted ultracentrifugation of EGFP fused Src, 
observing both monomeric and dimeric forms. These studies suggest the possibility that Src 
may form dimers, but the lack of myristoylation, the presence of dimerizing tags, or the lack 
of in cell evidence has not allowed confirmation and insightful analysis of dimerization. Le 
Roux et al. (2016a, 2016b) studied the kinetics of in vitro liposome binding to N-terminal 
Src regions and reported that the myristoylated SH4 region alone binds with kinetics that 
suggest dimerization is involved. The near-complete lack of protein content in this minimal 
construct and its dependency on lipid composition in the liposome may indicate the role of 
this region in the clustering of Src at the membrane and in membrane microdomains rather 
than dimerization involving protein interfaces. The arrangement of Src in some packed 
crystal structures of KD fragments has been interpreted as dimeric (Breitenlechner et al., 
2005), but the relevance of these crystal findings to the physiologic structure of the full-
length native protein is doubtful.
The importance of Src myristoylation has been known for some time, but this has largely 
been attributed to its role in mem-brane localization. Src constructs defective in 
myristoylation have altered phosphorylation activities (Bagrodia et al., 1993; Linder and 
Burr, 1988) and loss of transforming ability (Kamps et al., 1985, 1986), but the functions of 
the myristoyl moiety exceed beyond simple membrane localization. In some proteins, 
myristate is known to bind intramolecularly within hydrophobic pockets of the protein. In 
these scenarios, alternative binding modes (i.e., to the membrane versus the protein) affect 
protein function and define a myristoyl switch, such as seen in HIV-1 gag, recoverin, and 
Abl (Ames et al., 1995, 1996; Hantschel et al., 2003; Nagar et al., 2003; Resh, 2004; Tanaka 
et al., 1995). Src may also be regulated by a myristoyl switch, and our results support this 
model, but structural evidence for such a binding mode has thus far eluded crystallographic 
studies. Patwardhan and Resh (2010) conducted a biochemical analysis of myristoylated and 
non-myristoylated Src and reported effects on kinase activity, a possible association with the 
KD hydrophobic pocket, and enhanced protein stability and half-life. These are partly 
consistent with our findings, but this study did not investigate dimerization or signaling 
functions. The importance of the N-terminal UD for autophosphorylation activity has been 
demonstrated for the more distantly SFK-related protein Srms. The N-terminal UD of this 
protein is required for its catalytic activity (Goel et al., 2013), although the lack of N-
terminal myristoylation in Srms highlights key differences between these distantly related 
kinases.
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CONTACT FOR REAGENT AND RESOURCE SHARING
Requests for information and reagents should be directed to and will be fulfilled by the Lead 
Contact, Mark M. Moasser at the University of California, San Francisco Helen Diller 
Family Comprehensive Cancer Center, mark.moasser@ucsf.edu.
EXPERIMENTAL MODEL AND SUBJECT DETAILS
SYF, HEK293T, MDA_MB-468, and MDA-MB-231 cell lines were obtained from the 
American Type Culture Collection and grown in DMEM/F12 medium containing 10% fetal 
bovine serum, and 1% (v/v) penicillin–streptomycin solution. KM20 and WiDr cells were a 
gift from Dr. Michael Korn and were grown in the same medium.
METHOD DETAILS
Plasmid constructs—The cloning strategy was based on the Gateway system 
(ThermoFisher Scientific). The pDEST40 vector was modified to have either 2xHA or 
2xFLAG tags in-frame at the C terminus of the inserts. The mutant constructs were 
generated in pDONR221 vectors and subsequently shuttled into both pDEST40-2XHA and 
pDEST40-2XFLAG destination vectors. In the constructs designed for protein purification, 
the V5, HA, or FLAG tags were fused in frame with the carboxyl terminus, followed by a 
PreScission protease cleavage site and an in-frame GST (pDEST40-PP-GST).
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The coding sequence of human c-Src was amplified from c-Src cDNA clone sc125208 
(Origene). The primer sequences for this and all other construct cloning and mutation are 
provided in Table S1. Some constructs were cloned by amplification of the desired segment 
with appropriate primer extensions for cloning into pDONR221. The amplified PCR product 
was recombined by using BP Clonase II (ThermoFisher Scientific) into pDonR221. Some 
constructs were made by deletion cloning, i.e., outward PCR amplification of the entire 
plasmid omitting the desired deletion region. These were done by low number amplification 
cycles using Pfu Ultra HF polymerase and 50 phosphorylated primers followed by a self 
ligation reaction and DpnI digestion. Point mutations were created by site-directed 
mutagenesis using Pfu Ultra HF polymerase, whole plasmid amplification, followed by 
DpnI digestion and ligation in bacteria. All constructs were sequenced across the insert to 
verify the identity of the construct and rule out the presence of undesired mutations. The 
constructs in pDONR221 were moved to destination vectors using LR Clonase II 
(ThermoFisher).
Purification of src proteins—Plasmids containing the desired WT or mutant Src 
constructs with in-frame C-terminal tags (V5, HA,FLAG) followed by a PreScission 
protease cleavage site and GST were transfected in HEK293T cells (typically 40–60 µg 
plasmid per 15 cm dish). Next day the cells were treated with 1mM dasatinib (unless 
otherwise stated) for 1 hour to dephosphorylate Src and cells lysed in HEK293T cells lysis 
buffer (20mM Tris HCL, pH 7.5, 1% Triton X-100, 10% Glycerol, 400 mM NaCl, 1mM 
EDTA, 200 nM DTT, 1 mM PMSF, 2 µg/ml Leupeptin, 2 µg/ml Aprotinin, 1 nM sodium 
vanadate). The lysates were incubated at 4ºC for 30 minutes with constant rotation, and then 
centrifuged at 16,000 g for 5 min. The supernatant was collected and incubated with 
Glutathione Sepharose 4B beads (GE Healthcare)at 4ºC for 3 hours with constant rotation. 
The beads were washed 4 times with HEK293T lysis buffer and once with PPCB 
(PreScission Protease Cleavage Buffer: 50 mM Tris-HCl, 150 mM NaCl, 1 mM EDTA, 1 
mM dithiothreitol (DTT), pH 7.0). Next the beads were incubated with 1U PreScission 
protease (GE Healthcare) in PPCB at 4ºC overnight with constant rotation. Next day the 
supernatant, containing the purified src proteins was carefully collected. Typically, around 
10% of the sample was run in a gel for Coumassie staining. The purified proteins were 
stored at −20ºC in 50% glycerol.
Split SNAP-tag complementation assay—The split SNAP-tag complementation assay 
was performed by splitting the SNAP tag into nSNAP and cSNAP fragments following 
Gln91 according to a previously established complementation assay for living cells (Mie et 
al., 2012). Modified pDEST40 vectors were engineered with c-terminal nSNAP or cSNAP 
tags following 2XHA or 2XFLAG tags to generate pDEST40-2XHA-nSNAP and 
pDEST40-2XFLAG-cSNAP expression vectors. All constructs were confirmed by 
sequencing. WT and mutant Src inserts were then cloned into these vectors. These vectors 
were transfected into SYF cells using Lipofectamine 2000 according to the manufacturer’s 
instructions (Invitrogen). 24h after transfection, cells were labeled with SNAP-Cell Oregon 
Green (1 uM) for 30min. The cells were washed three times to remove unreacted substrate, 
counterstained with 5uM Hoescht 33342 for 2 minutes and incubated in fresh medium for 30 
min. Cells were fixed with 4% formaldehyde solution (Thermo Scientific) and 
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permeabilized with 0.02% Triton X-100. Cells were blocked and stained with the indicated 
anti-HA antibody (Y-11 sc-805 Rb) at 1:500 and anti-FLAG Ab (Sigma F1804 Ms) at 1:200 
followed by the appropriate secondary antibodies conjugated with Alexa Fluor 546 
(excitation at 488 nm and emission at 585–615 nm) or Alexa Fluor 647 (excitation at 633 
nm and emission from 650 nm). Cells were imaged using a Spinning disk confocal Nikon TI 
inverted microscope (× 40 objective, lasers 405, 488, 561 and 648 nm). For each 
transfection, at least 49 cells were analyzed using ImageJ. The complementation signal was 
plotted as a function of expression levels of the individual constructs.
Immunoprecipitation assays—Equal amounts (250ng-2 µg) of indicated HA and 
FLAG–tagged src constructs were co-transfected in SYF cells (6cm or 10 cm dishes). Total 
cellular lysates were harvested in modified RIPA buffer (10 mM Na phosphate (pH 7.2), 150 
mM NaCl, 0.1% SDS, 1% NP40, 1% Na deoxycholate, protease inhibitors and 1mM sodium 
orthovanadate). For immunoprecipitation studies, 200–300ug of lysate in mRIPA was 
incubated overnight with mouse anti- HA antibodies (clone F7, SantaCruz Biotechnology), 
immune complexes collected by protein G-Sepharose beads (GE Healthcare), washed, and 
the denatured complexes separated by SDS-PAGE, transferred to membranes, and 
immunoblotted with appropriate antibodies. For western blotting, 30ug of each lysate was 
separated by SDS-PAGE, transferred to membrane, and immunoblotted using appropriate 
primary and secondary antibodies and enhanced chemoluminescence visualization.
For detection of Src dimers using native gel electrophoresis, Src and SrcG2A constructs 
were purified from HEK293T cells as described above. Equal amounts of purified Src and 
SrcG2A were loaded into nativePAGE Novex Bis-Tris gels (Life Technologies). 
Electrophoresis was performed in the presence of Coomassie G-250 in the cathode buffer 
according to the manufacturer’s instructions (#BN1002BOX Life Technologies). Gels were 
transferred onto a PVDF membrane and blocked with 3% bovine serum albumin. The 
membranes were stained with primary antibodies overnight at 4ºC, washed 3 times with 
TBST (Tris-buffered saline containing 0.5% tween), stained with secondary antibodies for 1 
hour at room temperature and detected using the chemiluminescence method.
In vitro interaction of purified S4-UD with KD—For purification of the N-terminal 
S4-UD region fused to GST, the construct did not contain the Precision Protease cleavage 
site. The S4-UD-GST fusion construct was expressed in HEK293T cells and lysates loaded 
on Glutathione Sepharose 4B beads (GE Healthcare) at 4ºC for 3 hours and subsequently 
washed 4 times with HEK293T lysis buffer and once with mRIPA. To demon-strate the 
interaction with the KD, the purified Src KD was incubated with the S4-UD-GST bound 
beads at 4ºC overnight in mRIPA buffer. Next day the bound proteins were eluded with 
Elution Buffer (25 mM glutathione, 50 mM Tris, pH 8.8, 10 mM DTT, 200 mM NaCl, 10% 
glycerol)) and boiled in Laemmli buffer. The proteins were separated by SDS-PAGE and 
immunoblotted.
In vitro dimerization of purified src proteins—HA and FLAG tagged src constructs 
containing Y530F mutation were purified from HEK293T cells as described above, but the 
cells were not treated with dasatinib to preserve the endogenous Y419 phosphorylation. The 
src proteins were dialyzed against buffer D (50 mM Tris-HCl, 150 mM NaCl) by using 
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Slide-A-Lyzer MINI Dialysis Devices (ThermoFisherScientific). The dialyzed proteins were 
co-incubated in the presence of kinase assay buffer (see below) and immunoprecipitated 
with mouse anti-HA antibody, or normal mouse IgG control antibodies. The immune 
complexes were washed and boiled, separated on SDS-PAGE, transferred to membrane, and 
immunoblotted with anti-FLAG antibodies.
In vitro kinase assay—The kinase assay buffer and ATP were purchased from 
SignalChem (Richmond, BC). The indicated amounts of purified src proteins were incubated 
in kinase assay buffer (5 mM MOPS, pH7.2, 2.5 mM B-glycerol-phosphate, 4 mM MgCl2, 
2.5 mM MnCl2, 1 mM EGTA, 0.4 mM EDTA, 10 mM DTT, 250 mM ATP) at 30ºC for 10–
30 min. The reactions were stopped with 5x Laemmli buffer and boiling for 5 min. The 
results were analyzed by SDS-PAGE and western blotting. Recombinant human Paxillin was 
purchased from Raybiotech (Norcross, GA) and recombinant Enolase (ENO3) was 
purchased from Sino Biological Inc.(Beijing, PRC). All recombinant proteins used as 
substrates were purified from bacteria and therefore were not phosphorylated prior to the 
kinase reactions. HEK293T cells, transfected with the desired src constructs were treated 
with 1 mM dasatinib (Src and Csk inhibitor) to dephosphorylate Src for 1 hour prior to lysis.
Extraction of membrane and cytosolic fractions—Separation of membrane and 
cytosolic fractions was performed with Mem-Per™ Plus Membrane Protein Extraction Kit 
(ThermoFisher Scientific). Briefly, the FLAG-tagged versions of indicated src constructs 
were transfected in SYF cells. Next day the cells were lysed in Permeabilization buffer and 
span 16,000 g for 15 min. The supernatant containing cytosolic proteins was care-fully 
transferred to a new tube. Any residual droplets of supernatant that still remain around the 
pellets were removed carefully with P10 pipette. Next the pellets were resuspended in 
Solubilization buffer and incubated at 4ºC for 30 minutes with constant mixing. After 
spinning at 16,000 × g for 15 minutes at 4ºC, the supernatants containing solubilized 
membrane and membrane-associated proteins were collected. The collected cytosolic and 
membrane proteins were run on SDS-PAGE and visualized with anti-FLAG antibodies. The 
efficiency of fractionation procedure was monitored with antibodies against HSP90 
(localizes to the cytosolic frac-tion) and Caveolin-1 (localizes to the membrane fraction).
QUANTIFICATION AND STATISTICAL ANALYSIS
Quantification of image-based signals was done using ImageJ software (https://
imagej.nih.gov/).
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Highlights
• Src exists in cells as dimers
• The unique domain of one partner interacts with the kinase domain of another 
partner
• The myristoyl group is involved in binding a hydrophobic pocket in the kinase 
domain
• Dimerization and autophosphorylation are codependent events
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Figure 1. Index to Constructs
The various constructs designed for use in this study are shown here with the nomenclature 
used to refer to them. All constructs were created in both HA- and FLAG-tagged versions 
for easy analysis of dimerization. In addition, some of these constructs were further 
modified by point mutations and these are indicated in the figure labels.
Spassov et al. Page 25
Cell Rep. Author manuscript; available in PMC 2018 November 09.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Figure 2. Dimerization of Src Requires the N-Terminal Region and Kinase Domain
(A–H) SYF cells were transfected with the indicated constructs. HA-tagged proteins were 
immunoprecipitated from cell lysates and immunoblotted with the indicated antibodies. 
Immunoblots of whole-cell lysates were also performed as indicated.
(I) Y530F mutant of Src tagged with HA or FLAG was purified from HEK293T cells. The 
Y530F mutant was used to best demonstrate in vitro dimerization, since Src purified from 
these cells has significant Y530 phosphorylation and can promote the closed conformation. 
Coomassie stains of the purified proteins are shown on the left. The purified proteins were 
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mixed and incubated for 2 hr, followed by addition of anti-HA antibodies or isotype control 
immunoglobulin G (IgG). The anti-HA immunoprecipitates were immunoblotted as 
indicated and shown on the right. A portion of the input mixture prior to 
immunoprecipitation was also immunoblotted as indicated.
(J) Src and SrcG2A constructs were purified from HEK293T cells and analyzed in blue 
native gels followed by immunoblot using anti-Src antibody.
(K) The GST-tagged S4-UD construct was expressed and purified from HEK293T cells by 
pull-down on glutathione Sepharose beads. The FLAG-tagged KD construct was expressed 
and purified from HEK293T cells by glutathione sepharose beads and the GST tag cleaved 
off. The purified proteins were mixed and incubated overnight at 4ºC in mRIPA buffer; 
beads were pulled down, eluted in GST elution buffer, separated by SDS-PAGE, and 
immunoblotted as indicated. Experiments with the various constructs were performed 2–4 
times, and representative data are shown here.
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Figure 3. Dimerization of Src Is Directly Evident in Living Cells
(A) SYF cells were transfected with the indicated dual constructs carrying complementary 
nSNAP and cSNAP tags. The expression of each of the two constructs was evaluated by 
anti-HA and anti-FLAG immunostaining, and their interaction was evaluated by the SNAP-
cell reagent using fluorescence reporters selected for comfortable spectral separation. 
Images were obtained using a spinning-disk inverted confocal microscope and a 40× 
objective. Scale bars, 10 µm.
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(B) The two expression signals and the complementation signal were quantified in 
individual cells in the WT Src transfection and the S32-KD construct transfection. The 
expression of the two constructs (from HA and FLAG immunostains) is depicted in the x 
and y axes, whereas the intensity of the complementation signal is depicted in the diameter 
of the circles on the graph and has been corrected for background evident in vector 
transfected controls. Complementation of the full-length WT Src is best compared with the 
S32-KD construct in ranges of similar expression such as the 2–8 ranges along the x and y 
axes. Experiments were done 3 times, and representative data are shown here.
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Figure 4. Dimerization of Src Requires Y419 Autophosphorylation in cis with the N-Terminal 
Region
(A–C) SYF cells were transfected with the indicated constructs. HA-tagged proteins were 
immunoprecipitated from cell lysates and immunoblotted with the indicated antibodies. 
Immunoblots of whole-cell lysates were also performed as indicated.
(D) SYF cells were transfected with HA-tagged and FLAG-tagged full-length wild-type Src 
and treated with DMSO control or 1 mM dasatinib and anti-HA immunoprecipitates were 
immunoblotted as indicated. The dasatinib treatment was started either early or late or for 
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short or long durations as indicated. For more clarity, the treatment timeline is shown 
graphically in Figure S3.
(E and F) SYF cells were transfected with the indicated constructs. HA-tagged proteins were 
immunoprecipitated from cell lysates and immunoblotted with the indicated antibodies. 
Immunoblots of whole-cell lysates were also performed as indicated.
(G) SYF cells were transfected with the indicated higher or lower migrating Src constructs, 
and cell lysates were immunoblotted as indicated. Experiments with the various constructs 
were performed 2–4 times, and representative data are shown here.
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Figure 5. Dimerization of Src Is Mediated through a Kinase Domain Hydrophobic Pocket in 
trans with the N-Terminal Region
(A) The region of the putative hydrophobic pocket within the C-lobe of the Src kinase 
domain is shown from structure 2SRC. The residues mutated to widen or narrow the pocket 
are indicated.
(B–E) SYF cells were transfected with the indicated constructs. HA-tagged proteins were 
immunoprecipitated from cell lysates and immunoblotted with the indicated antibodies. 
Immunoblots of whole-cell lysates were also performed as indicated. The double bands seen 
in some immunoblots are due to a higher migrating Y338-phosphorylated form of Src as 
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determined in additional experiments. Experiments with the various constructs were 
performed twice, and representative data are shown here.
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Figure 6. The N-Terminal Region of Src Regulates Catalytic Activity
(A and B) SYF cells were transfected with the indicated constructs and cell lysates 
immunoblotted as indicated.
(C) The indicated full-length or partial length Src constructs were expressed and purified 
from dasatinib-treated HEK293T cells. Dasatinib treatment was to enable the purification of 
unphosphorylated Src. Coomassie stains of the purified proteins are shown here.
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(D) In vitro kinase reactions were carried with 10 nM of the indicated purified V5-tagged 
Src proteins for 10 min and assayed by anti-pY419Src immunoblotting. ATP was omitted in 
the negative control arms.
(E) The same in vitro kinase reactions were performed using different concentrations of 
protein as indicated. The quantified autophosphorylation results are shown here, and the 
corresponding immunoblots of these reactions are shown in Figure S6. The data points 
represent the average of n = 2; errors bars represent SEM.
(F) Three separate in vitro kinase reactions were performed using 4 nM Src proteins and 
each of the three indicated purified recombinant substrates. Kinase reaction linear conditions 
were previously established and are as follows: 40 nM paxillin in reaction for 20 min, 250 
nM enolase in reaction for 20 min, and 70 nM Trask/CDCP1 in reaction for 10 min. 
Substrate phosphorylation was assayed by anti-pTyr immunoblotting and kinase and 
substrate proteins immunoblotted with V5 and substrate-specific antibodies. ATP was 
omitted in the negative control arms.
(G) The indicated cell lines were treated with 1 µM DDD85646 for 30 hr and cell lysates 
immunoblotted as indicated. Anti-pY416Src antibodies cross-react with all members of the 
Src family.
(H) The same lysates were assayed specifically for Src autophosphorylation by anti-Src 
immunoprecipitation and immunoblotted as indicated. Experiments with the various 
constructs were performed 2–3 times, and representative data are shown here.
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Figure 7. Interfering with Src Dimerization Disrupts Signaling
(A) SYF cells were transfected with the indicated constructs. HA-tagged proteins were 
immunoprecipitated from cell lysates and immunoblotted with the indicated antibodies. 
Immunoblots of whole-cell lysates were also performed as indicated.
(B) SYF cells were transfected with the indicated constructs and cell lysates immunoblotted 
as indicated.
(C) SYF cells were transfected with the indicated constructs. HA-tagged proteins were 
immunoprecipitated from cell lysates and immunoblotted with the indicated antibodies. 
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Immunoblots of whole-cell lysates were also performed as indicated. Experiments were 
performed twice, and representative data are shown here.
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